Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

World Premiere Of Innovative Medical Devices For Neurosurgery
Renishaw, a world leader in engineering technologies, is introducing an exciting range of high precision systems for functional and stereotactic neurosurgery at the 15th Quadrennial Meeting of the World Society for Stereotactic and Functional Neurosurgery (WSSFN) taking place in Toronto, Canada, from May 24th to 27th 2009. These include the neuromate® surgical robot, and image-guided stereotactic technologies, some of which are still in development.
generic viagra online
Yale Researchers Suggests Gene Inhibition May Help Normalize Type 2 Diabetes
In research that could lead to new approaches for the treatment of type 2 diabetes, a Yale School of Medicine team has found that suppressing a liver enzyme that induces glucose production helped diminish the symptoms of the disease in a rat model - reducing blood glucose concentrations, decreasing rates of glucose production in the liver, and improving insulin sensitivity. Decreasing expression of the gene, Sirtuin 1, also lowered total cholesterol levels.
News of the day
What Are Bed Bugs? How To Kill Bed Bugs
Bed bugs, known scientifically as Cimex lectularius (Cimicidae) are small wingless insects that feed by hematophagy - exclusively on the blood of warm blooded-animals. As we are warm-blooded animals we are ideal hosts for them. Over millions of years bed bugs have evolved as nest parasites - inhabiting the nests of birds and the roosts of bats. Some of them have learnt to adapt to the human environment and live in our nests, i.e. our homes, and more specifically, our beds. Newborns, called hatchlings or nymphs, are tiny, about the size of a poppy seed, while adults grow to about ÂÜ of an inch long. Their shape is oval and flattened. Both nymphs, eggs and adults are visible to the naked eye.
Mental Health

New Glaucoma Treatment To Be Piloted, Wales

New ways of diagnosing and treating patients with glaucoma will be piloted in two areas in Wales, Health Minister Edwina Hart announced today. The ophthalmic diagnostic centre pilot will evaluate the feasibility of diagnosing and monitoring of glaucoma by optometrists working in the community, supported by hospital consultants. Subject to the outcome of the pilot, plans will be developed to roll it out across Wales. A number of Optometrists at two centres will be selected to perform the diagnostic tests and Ophthalmologists will be available at hospital to view this information and data electronically and recommend treatment as required. The pilot will begin at the Highlight Park GP surgery, Barry on 1 September and start at the optometry practice in Llandeilo a few weeks later and run for six months. The ÷£181,800 cost of the pilot will be funded by the Assembly Government. Mrs Hart said: "It is important that patients receive swift access to diagnosis to determine the best course of treatment. Initially, the pilot will provide the mechanism for patients with stable glaucoma or ocular hypertension to be followed up in the community, close to home. "This will avoid unnecessary hospital outpatient visits. As the pilot develops, so will the clinical experience to provide an all Wales service to enhance glaucoma care to patients in Wales. "The two new centres - one in a rural and one in an urban community - will help us to evaluate the feasibility of providing this services in the community rather than in hospitals. This will ultimately benefit patients as they will be able to receive the appropriate care and support closer to home." Mr Richard Roberts, Chief Optometric Advisor to the Welsh Assembly Government, added: "Glaucoma and ocular hypertension currently account for the largest group of patients requiring regular, long-term management for eye disease accounting for more than 30,000 patients every year. It is estimated 10,000 could be managed within an ophthalmic diagnostic unit. It is also the commonest cause of irreversible, yet preventable, blindness in Wales. "Glaucoma generally affects people as they get older, mainly people over 60. As Wales" population continues to get older, which is something that we should celebrate, there is an increasing likelihood that more people will require tests and treatment for glaucoma. It is therefore important we look at ways to increase capacity so that we will be able to meet this demand swiftly and effectively." Welsh Assembly Government


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009